| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Daniel Gruskin | Chief Medical Officer | 16 Nov 2022 | |||
| Jeff Goater | Director | 16 Nov 2022 | |||
| MOSCICKI RICHARD A | Director | 16 Nov 2022 | |||
| Cecilia Jones | Chief Financial Officer | 01 Mar 2022 | |||
| Leon Chen | Director | 16 Nov 2022 | |||
| Mark J. Enyedy | Director | 16 Nov 2022 | |||
| Mark A. Kay | Director | 16 Nov 2022 | |||
| Daphne Karydas | Director | 16 Nov 2022 | |||
| Susan Kahn | Director | 16 Nov 2022 | |||
| Mariana Nacht | Chief Scientific Officer | 16 Nov 2022 | |||
| Michael S. Wyzga | Director | 16 Nov 2022 | |||
| Frederic Chereau | President, CEO, Director | 16 Nov 2022 | |||
| Andrea Paul | General Counsel and Secretary | 01 Mar 2022 | |||
| Joshua Blacher | Interim CFO | 23 Sep 2022 |
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||